Epitranscriptomic control of telomere maintenance

dc.contributor.authorPashay Ahi, Ehsan
dc.contributor.authorGhasemishahrestani, Zeinab
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id522855690
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/522855690
dc.date.accessioned2026-04-24T15:50:57Z
dc.description.abstract<p>Telomere maintenance has been portrayed primarily as a problem of DNA–protein architecture and chromatin control, yet a complementary layer has been revealed at the level of RNA chemistry. In this Review, RNA modifications and their writer–reader–eraser and RNA-editing systems are integrated into a framework for chromosome-end homeostasis. Epitranscriptomic regulation of the telomerase ribonucleoprotein is examined, and assembly, activity, and recruitment are shown to be reshaped by chemical marks on TERC, specialized RNA capping, and processing pathways. Telomeric transcripts, particularly TERRA, are discussed as modified substrates whose stability, trafficking, and propensity for telomeric RNA: DNA hybrid formation can be tuned by RNA marks and their readers. Downstream consequences for replication stress, DNA damage signaling, and recombination-driven alternative lengthening of telomeres are summarized, together with emerging examples in which modification of telomere-factor mRNAs has been linked to rewiring of maintenance networks. Across these themes, links to telomeropathies, aging-associated inflammation, environmental stressors, and cancer are collated to connect mechanism to phenotype. Experimental bottlenecks and opportunities—site-resolved mapping, locus-targeted editing, and pharmacologic modulation of RNA-modifying enzymes—are outlined as routes toward causal models and therapeutic utilization.<br></p>
dc.identifier.eissn1573-4978
dc.identifier.jour-issn0301-4851
dc.identifier.urihttps://www.utupub.fi/handle/11111/58571
dc.identifier.urlhttps://doi.org/10.1007/s11033-026-11699-w
dc.identifier.urnURN:NBN:fi-fe2026042332764
dc.language.isoen
dc.okm.affiliatedauthorPashay Ahi, Ehsan
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisherSpringer Nature
dc.publisher.countryNetherlandsen_GB
dc.publisher.countryAlankomaatfi_FI
dc.publisher.country-codeNL
dc.relation.articlenumber513
dc.relation.doi10.1007/s11033-026-11699-w
dc.relation.ispartofjournalMolecular Biology Reports
dc.relation.volume53
dc.titleEpitranscriptomic control of telomere maintenance
dc.year.issued2026

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s11033-026-11699-w.pdf
Size:
1.93 MB
Format:
Adobe Portable Document Format